Placental lactogen (PL) induced serotonergic signaling is essential for gestational β-cell mass expansion. We have previously shown that intact Epidermal growth factor –receptor (EGFR) function is a crucial component of this pathway. We now explored more specifically the link between EGFR and pregnancy-induced β-cell mass compensation. Islets were isolated from wild-type and β-cell-specific EGFR-dominant negative mice (E1-DN), stimulated with PL and analyzed for β-cell proliferation and expression of genes involved in gestational β-cell growth. β-cell mass dynamics were analyzed both with traditional morphometrical methods and three-dimensional optical projection tomography (OPT) of whole-mount insulin-stained pancreata. Insulin-positive volume analyzed with OPT increased 1.4-fold at gestational day 18.5 (GD18.5) when compared to non-pregnant mice. Number of islets peaked by GD13.5 (680 vs 1134 islets per pancreas, non-pregnant vs. GD13.5). PL stimulated beta cell proliferation in the wild-type islets, whereas the proliferative response was absent in the E1-DN mouse islets. Serotonin synthesizing enzymes were upregulated similarly in both the wild-type and E1-DN mice. However, while survivin (Birc5) mRNA was upregulated 5.5-fold during pregnancy in the wild-type islets, no change was seen in the E1-DN pregnant islets. PL induced survivin expression also in isolated islets and this was blocked by EGFR inhibitor gefitinib, mTOR inhibitor rapamycin and MEK inhibitor PD0325901. Our 3D-volumetric analysis of β-cell mass expansion during murine pregnancy revealed that islet number increases during pregnancy. In addition, our results suggest that EGFR signaling is required for lactogen-induced survivin expression via MAPK and mTOR pathways.
References
[1]
Parsons J, Brelje T, Sorenson R (1992) Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. Endocrinology 130: 1459–1466. doi: 10.1210/endo.130.3.1537300
[2]
Sorenson RL, Brelje TC (1997) Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res 29: 301–307. doi: 10.1055/s-2007-979040
[3]
Huang C, Snider F, Cross JC (2009) Prolactin receptor is required for normal glucose homeostasis and modulation of beta-cell mass during pregnancy. Endocrinology 150: 1618–1626. doi: 10.1210/en.2008-1003
[4]
Brelje TC, Svensson AM, Stout LE, Bhagroo NV, Sorenson RL (2002) An immunohistochemical approach to monitor the prolactin-induced activation of the JAK2/STAT5 pathway in pancreatic islets of Langerhans. J Histochem Cytochem 50: 365–383. doi: 10.1177/002215540205000308
[5]
Amaral MEC, Ueno M, Carvalheira JB, Carneiro EM, Velloso LA, et al. (2003) Prolactin-signal transduction in neonatal rat pancreatic islets and interaction with the insulin-signaling pathway. Horm Metab Res 35: 282–289. doi: 10.1055/s-2003-41303
[6]
Rieck S, White P, Schug J, Fox AJ, Smirnova O, et al. (2009) The transcriptional response of the islet to pregnancy in mice. Mol Endocrinol 23: 1702–1712. doi: 10.1210/me.2009-0144
[7]
Schraenen A, Lemaire K, Faudeur G, Hendrickx N, Granvik M, et al. (2010) Placental lactogens induce serotonin biosynthesis in a subset of mouse beta cells during pregnancy. Diabetologia 53: 2589–2599. doi: 10.1007/s00125-010-1913-7
[8]
Schraenen A, de Faudeur G, Thorrez L, Lemaire K, Van Wichelen G, et al. (2010) mRNA expression analysis of cell cycle genes in islets of pregnant mice. Diabetologia 53: 2579–2588. doi: 10.1007/s00125-010-1912-8
[9]
Kim H, Toyofuku Y, Lynn FC, Chak E, Uchida T, et al. (2010) Serotonin regulates pancreatic beta cell mass during pregnancy. Nature Medicine 16: 804–808. doi: 10.1038/nm.2173
[10]
Zhang H, Zhang J, Pope CF, Crawford LA, Vasavada RC, et al. (2010) Gestational diabetes mellitus resulting from impaired beta-cell compensation in the absence of FoxM1, a novel downstream effector of placental lactogen. Diabetes 59: 143–152. doi: 10.2337/db09-0050
[11]
Karnik SK, Chen H, McLean GW, Heit JJ, Gu X, et al. (2007) Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus. Science 318: 806–809. doi: 10.1126/science.1146812
[12]
Hakonen E, Ustinov J, Mathijs I, Palgi J, Bouwens L, et al. (2011) Epidermal growth factor (EGF)-receptor signalling is needed for murine beta cell mass expansion in response to high-fat diet and pregnancy but not after pancreatic duct ligation. Diabetologia 54: 1735–1743. doi: 10.1007/s00125-011-2153-1
[13]
Rieck S, Kaestner KH (2010) Expansion of beta-cell mass in response to pregnancy. Trends Endocrinol Metab 21: 151–158. doi: 10.1016/j.tem.2009.11.001
[14]
Parsons J, Bartke A, Sorenson R (1995) Number and size of islets of Langerhans in pregnant, human growth hormone-expressing transgenic, and pituitary dwarf mice: effect of lactogenic hormones. Endocrinology 136: 2013–2021. doi: 10.1210/endo.136.5.7720649
[15]
Abouna S, Old RW, Pelengaris S, Epstein D, Ifandi V, et al. (2010) Non-β-cell progenitors of β-cells in pregnant mice. Organogenesis 6: 125–133. doi: 10.4161/org.6.2.10374
[16]
Butler AE, Cao-Minh L, Galasso R, Rizza RA, Corradin A, et al. (2010) Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia 53: 2167–2176. doi: 10.1007/s00125-010-1809-6
[17]
Alanentalo T, Asayesh A, Morrison H, Lorén CE, Holmberg D, et al. (2006) Tomographic molecular imaging and 3D quantification within adult mouse organs. Nat Methods 4: 31–33. doi: 10.1038/nmeth985
[18]
Alanentalo T, H？rnblad A, Mayans S, Karin Nilsson A, Sharpe J, et al. (2010) Quantification and three-dimensional imaging of the insulitis-induced destruction of beta-cells in murine type 1 diabetes. Diabetes 59: 1756–1764. doi: 10.2337/db09-1400
[19]
Miettinen PJ, Ustinov J, Ormio P, Gao R, Palgi J, et al. (2006) Downregulation of EGF receptor signaling in pancreatic islets causes diabetes due to impaired postnatal beta-cell growth. Diabetes 55: 3299–3308. doi: 10.2337/db06-0413
[20]
Hakonen E, Ustinov J, Eizirik DL, Sariola H, Miettinen PJ, et al.. (2014) In vivo activation of the PI3K-Akt pathway in mouse beta cells by the EGFR mutation L858R protects against diabetes. Diabetologia. doi:10.1007/s00125-014-3175-2.
[21]
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–408. doi: 10.1006/meth.2001.1262
[22]
Peng X-H, Karna P, Cao Z, Jiang B-H, Zhou M, et al. (2006) Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem 281: 25903–25914. doi: 10.1074/jbc.m603414200
[23]
Huotari M-A, Miettinen PJ, Palgi J, Koivisto T, Ustinov J, et al. (2002) ErbB signaling regulates lineage determination of developing pancreatic islet cells in embryonic organ culture. Endocrinology 143: 4437–4446. doi: 10.1210/en.2002-220382
[24]
Vinter-Jensen L, Juhl C, Teglbjaerg P, Poulsen S, Dajani E, et al. (1997) Systemic treatment with epidermal growth factor in pigs induces ductal proliferations in the pancreas. Gastroenterology 113: 1367–1374. doi: 10.1053/gast.1997.v113.pm9322532
[25]
Means AL, Ray KC, Singh AB, Washington MK, Whitehead RH, et al. (2003) Overexpression of heparin-binding EGF-like growth factor in mouse pancreas results in fibrosis and epithelial metaplasia. Gastroenterology 124: 1020–1036. doi: 10.1053/gast.2003.50150
[26]
Cras-Meneur C, Elghazi L, Czernichow P, Scharfmann R (2001) Epidermal growth factor increases undifferentiated pancreatic embryonic cells in vitro: a balance between proliferation and differentiation. Diabetes 50: 1571–1579. doi: 10.2337/diabetes.50.7.1571
[27]
Daub H, Weiss FU, Wallasch C, Ullrich A (1996) Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379: 557–560. doi: 10.1038/379557a0
[28]
Holbro T, Hynes NE (2004) ErbB receptors: directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol 44: 195–217. doi: 10.1146/annurev.pharmtox.44.101802.121440
[29]
Huang Y, Li X, Jiang J, Frank SJ (2006) Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Oncogene 25: 7565–7576. doi: 10.1038/sj.onc.1209740
[30]
Frank SJ (2008) Mechanistic aspects of crosstalk between GH and PRL and ErbB receptor family signaling. J Mammary Gland Biol Neoplasia 13: 119–129. doi: 10.1007/s10911-008-9065-9
[31]
Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, et al. (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58: 5315–5320.
[32]
Kanwar JR, Kamalapuram SK, Kanwar RK (2011) Targeting survivin in cancer: the cell-signalling perspective. Drug Discov Today 16: 485–494. doi: 10.1016/j.drudis.2011.04.001
[33]
Wu X, Zhang Q, Wang X, Zhu J, Xu K, et al. (2012) Survivin is required for Beta-cell mass expansion in the pancreatic duct-ligated mouse model. PLoS ONE 7: e41976. doi: 10.1371/journal.pone.0041976
[34]
Jiang Y, Nishimura W, Devor-Henneman D, Kusewitt D, Wang H, et al. (2008) Postnatal expansion of the pancreatic beta-cell mass is dependent on survivin. Diabetes 57: 2718–2727. doi: 10.2337/db08-0170
[35]
Wu X, Wang L, Schroer S, Choi D, Chen P, et al. (2009) Perinatal survivin is essential for the establishment of pancreatic beta cell mass in mice. Diabetologia 52: 2130–2141. doi: 10.1007/s00125-009-1469-6
[36]
Dohi T, Salz W, Costa M, Ariyan C, Basadonna GP, et al. (2006) Inhibition of apoptosis by survivin improves transplantation of pancreatic islets for treatment of diabetes in mice. EMBO Rep 7: 438–443. doi: 10.1038/sj.embor.7400640
[37]
Wang Q, Greene MI (2005) EGFR enhances Survivin expression through the phosphoinositide 3 (PI-3) kinase signaling pathway. Exp Mol Pathol 79: 100–107. doi: 10.1016/j.yexmp.2005.05.002
[38]
Hanley SC, Assouline B, Makhlin J, Rosenberg L (2011) Epidermal Growth Factor Induces Adult Human Islet Cell Dedifferentiation. The Journal of endocrinology.
[39]
Rescan C, Le Bras S, Lefebvre VH, Frandsen U, Klein T, et al. (2005) EGF-induced proliferation of adult human pancreatic duct cells is mediated by the MEK/ERK cascade. Lab Invest 85: 65–74. doi: 10.1038/labinvest.3700204
[40]
Zarrouki B, Benterki I, Fontés G, Peyot M-L, Seda O, et al.. (2013) Epidermal Growth Factor Receptor Signaling Promotes Pancreatic β-Cell Proliferation in Response to Nutrient Excess in Rats through mTOR and FOXM1. Diabetes. doi:10.2337/db13-0425.
